Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Kaja Zuwala"'
Autor:
Mariane H. Schleimann, Maria-Louise Kobberø, Line K. Vibholm, Kathrine Kjær, Leila B. Giron, Kathleen Busman-Sahay, Chi Ngai Chan, Michael Nekorchuk, Manuel Schmidt, Burghardt Wittig, Tine E. Damsgaard, Peter Ahlburg, Michel B. Hellfritzsch, Kaja Zuwala, Frederik H. Rothemejer, Rikke Olesen, Phillipp Schommers, Florian Klein, Harsh Dweep, Andrew Kossenkov, Jens R. Nyengaard, Jacob D. Estes, Mohamed Abdel-Mohsen, Lars Østergaard, Martin Tolstrup, Ole S. Søgaard, Paul W. Denton
Publikováno v:
EBioMedicine, Vol 45, Iss , Pp 328-340 (2019)
Background: TLR9 agonists are being developed as immunotherapy against malignancies and infections. TLR9 is primarily expressed in B cells and plasmacytoid dendritic cells (pDCs). TLR9 signalling may be critically important for B cell activity in lym
Externí odkaz:
https://doaj.org/article/6617a90ba47a4cea9fc13ade7be6bc01
Autor:
Elisabeth A. Diget, Kaja Zuwala, Randi K. Berg, Rune R. Laursen, Stine Søby, Lars Østergaard, Jesper Melchjorsen, Trine H. Mogensen
Publikováno v:
Mediators of Inflammation, Vol 2013 (2013)
Macrophages play an important role in human immunodeficiency virus (HIV) pathogenesis and contribute to establishment of a viral reservoir responsible for continuous virus production and virus transmission to T cells. In this study, we investigated t
Externí odkaz:
https://doaj.org/article/6d1d2d9709754c578161dd7559a7f417
Autor:
Karen Singers Eiskjær Johansen, Martin Tolstrup, Frederik Dagnæs-Hansen, Alexander N. Zelikin, Kaja Zuwala, Anton A. A. Smith, Oliver Pilgram
Publikováno v:
Smith, A A A, Zuwala, K, Pilgram, O, Johansen, K S E, Tolstrup, M, Dagnæs-Hansen, F & Zelikin, A N 2016, ' Albumin–Polymer–Drug Conjugates: Long Circulating, High Payload Drug Delivery Vehicles ', ACS Macro Letters, vol. 5, pp. 1089-1094 . https://doi.org/10.1021/acsmacrolett.6b00544
Albumin is an exquisite tool of nature used in biomedicine to achieve long blood residence time for drugs, but the payload it can carry is typically limited to one molecule per protein. In contrast, synthetic macromolecular prodrugs contain multiple
Autor:
Mohamed Abdel-Mohsen, Jacob D. Estes, Martin Tolstrup, Manuel Schmidt, Kathleen Busman-Sahay, Line K. Vibholm, Andrew V. Kossenkov, Kathrine Kjær, Rikke Olesen, Michel Bach Hellfritzsch, Paul W. Denton, Michael Nekorchuk, Leila B. Giron, Lars Østergaard, Maria Louise Kobberø, Chi Ngai Chan, Tine Engberg Damsgaard, Peter Ahlburg, Mariane H. Schleimann, Jens R. Nyengaard, Phillipp Schommers, Florian Klein, Burghardt Wittig, Kaja Zuwala, Frederik H. Rothemejer, Harsh Dweep, Ole Schmeltz Søgaard
Publikováno v:
Schleimann, M H, Kobberø, M-L, Vibholm, L K, Kjær, K, Giron, L B, Busman-Sahay, K, Chan, C N, Nekorchuk, M, Schmidt, M, Wittig, B, Damsgaard, T E, Ahlburg, P, Hellfritzsch, M B, Zuwala, K, Rothemejer, F H, Olesen, R, Schommers, P, Klein, F, Dweep, H, Kossenkov, A, Nyengaard, J R, Estes, J D, Abdel-Mohsen, M, Østergaard, L, Tolstrup, M, Søgaard, O S & Denton, P W 2019, ' TLR9 agonist MGN1703 enhances B cell differentiation and function in lymph nodes ', EBioMedicine, vol. 45, pp. 328-340 . https://doi.org/10.1016/j.ebiom.2019.07.005
EBioMedicine
EBioMedicine
Background TLR9 agonists are being developed as immunotherapy against malignancies and infections. TLR9 is primarily expressed in B cells and plasmacytoid dendritic cells (pDCs). TLR9 signalling may be critically important for B cell activity in lymp
Autor:
Martin Tolstrup, Frederik Dagnæs-Hansen, Anna H. F. Andersen, Alexander N. Zelikin, Paul W. Denton, Kaja Zuwala, Camilla Frich Riber
Publikováno v:
Andersen, A H F, Frich, C K, Zuwala, K, Tolstrup, M, Dagnæs-Hansen, F, Denton, P W & Zelikin, A N 2018, ' Long-Acting, Potent Delivery of Combination Antiretroviral Therapy ', ACS Macro Letters, vol. 7, no. 5, pp. 587–591 . https://doi.org/10.1021/acsmacrolett.8b00179
Antiretroviral therapy (ART) has revolutionized HIV treatment, yet grand challenges remain: (i) short blood and body residence time of the antiviral drugs, (ii) relative poor antiretroviral drug penetrance into key tissue reservoirs of viral infectio
Autor:
Lise L. Sørensen, Camilla Frich Riber, Alexander N. Zelikin, Paulina Gajda, Martin Tolstrup, Anna H. F. Andersen, Kaja Borup Løvschall, Kaja Zuwala
Publikováno v:
Journal of Controlled Release
Riber, C F, Zuwala, K, Løvschall, K, Andersen, A H F, Sørensen, L, Gajda, P, Tolstrup, M & Zelikin, A N 2018, ' Macromolecular prodrugs of ribavirin : Polymer backbone defines blood safety, drug release, and efficacy of anti-inflammatory effects ', Journal of Controlled Release, vol. 275, no. April, pp. 53-66 . https://doi.org/10.1016/j.jconrel.2018.02.012
Riber, C F, Zuwala, K, Løvschall, K, Andersen, A H F, Sørensen, L, Gajda, P, Tolstrup, M & Zelikin, A N 2018, ' Macromolecular prodrugs of ribavirin : Polymer backbone defines blood safety, drug release, and efficacy of anti-inflammatory effects ', Journal of Controlled Release, vol. 275, no. April, pp. 53-66 . https://doi.org/10.1016/j.jconrel.2018.02.012
Macromolecular (pro)drugs hold much promise as broad-spectrum antiviral agents as either microbicides or carriers for intracellular delivery of antiviral drugs. Intriguing opportunity exists in combining the two modes of antiviral activity in the sam
Autor:
Ole Schmeltz Søgaard, Manuel Schmidt, Burghardt Wittig, Kaja Zuwala, Martin Tolstrup, Mariane H. Schleimann, Stephane Hua, Katharina Mack, Rikke Olesen, Anni Winckelmann, Line K. Vibholm, Mathias Lichterfeld, Sanne Skov Jensen, Vibeke Klastrup, Giacomo S. Frattari, Paul W. Denton, Nanna M. Jensen, Lars Østergaard, Christina V. Konrad
Publikováno v:
Vibholm, L K, Konrad, C V, Schleimann, M H, Frattari, G, Winckelmann, A, Klastrup, V, Jensen, N M, Schmidt, M, Wittig, B, Zuwala, K, Mack, K, Olesen, R, Hua, S, Lichterfeld, M, Østergaard, L, Denton, P W, Tolstrup, M & Søgaard, O S 2019, ' Effects of 24-week Toll-like receptor 9 agonist treatment in HIV type 1+ individuals ', AIDS (London, England), vol. 33, no. 8, pp. 1315-1325 . https://doi.org/10.1097/QAD.0000000000002213
DESIGN: This was an exploratory, single-arm clinical trial that tested the immune enhancement effects of 24-weeks of Toll-like receptor 9 (TLR9) agonist (MGN1703; Lefitolimod; 60 mg × 2 weekly) therapy. METHODS: We enrolled HIV-1-infected individual
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97789671b5831b91f2f21413c994b460
https://pure.au.dk/portal/da/publications/effects-of-24week-tolllike-receptor-9-agonist-treatment-in-hiv-type-1-individuals(39a77657-f724-4206-a780-5a6b6139fc80).html
https://pure.au.dk/portal/da/publications/effects-of-24week-tolllike-receptor-9-agonist-treatment-in-hiv-type-1-individuals(39a77657-f724-4206-a780-5a6b6139fc80).html
Publikováno v:
Chemical Science
Zuwala, K, Smith, A A A, Tolstrup, M & Zelikin, A N 2016, ' HIV anti-latency treatment mediated by macromolecular prodrugs of histone deacetylase inhibitor, panobinostat ', Chemical Science, vol. 7, no. 3, pp. 2353-2358 . https://doi.org/10.1039/c5sc03257a
Zuwala, K, Smith, A A A, Tolstrup, M & Zelikin, A N 2016, ' HIV anti-latency treatment mediated by macromolecular prodrugs of histone deacetylase inhibitor, panobinostat ', Chemical Science, vol. 7, no. 3, pp. 2353-2358 . https://doi.org/10.1039/c5sc03257a
Self-immolative linker and a disulfide trigger are used to design macromolecular prodrugs of panobinostat as efficacious HIV latency reversing agents.
Histone deacetylase inhibitors (HDACi) and panobinostat in particular are currently in the foc
Histone deacetylase inhibitors (HDACi) and panobinostat in particular are currently in the foc
Autor:
Florian Kreppel, Franziska Schandock, Janis A. Müller, Paulina Gajda, Kaja Zuwala, Jan Münch, Kaja Borup Løvschall, Anna H. F. Andersen, Mirja Harms, Martin Tolstrup, Camilla Frich Riber, Annika Röcker, Alexander N. Zelikin
Publikováno v:
Schandock, F, Riber, C F, Röcker, A, Müller, J A, Harms, M, Gajda, P, Zuwala, K, Andersen, A H F, Løvschall, K B, Tolstrup, M, Kreppel, F, Münch, J & Zelikin, A N 2017, ' Macromolecular Antiviral Agents against Zika, Ebola, SARS, and Other Pathogenic Viruses ', Advanced Healthcare Materials . https://doi.org/10.1002/adhm.201700748
Advanced Healthcare Materials
Advanced Healthcare Materials
Viral pathogens continue to constitute a heavy burden on healthcare and socioeconomic systems. Efforts to create antiviral drugs repeatedly lag behind the advent of pathogens and growing understanding is that broad‐spectrum antiviral agents will ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::053bee39f9568aa99758d859db2c32c1
https://pure.au.dk/portal/da/publications/macromolecular-antiviral-agents-against-zika-ebola-sars-and-other-pathogenic-viruses(6beaa39b-4eb1-4b35-8c97-7fa4549e97a6).html
https://pure.au.dk/portal/da/publications/macromolecular-antiviral-agents-against-zika-ebola-sars-and-other-pathogenic-viruses(6beaa39b-4eb1-4b35-8c97-7fa4549e97a6).html
Autor:
Camilla Frich Riber, Alexander N. Zelikin, Thomas Pietschmann, Martin Tolstrup, Kaja Zuwala, Lærke Anegaard Rolskov, Anna H. F. Andersen, Frederik Dagnæs-Hansen, Dominic H. Banda, Paulina Gajda, Kaja Borup Løvschall
Publikováno v:
Riber, C F, Halling Folkmar Andersen, A, Anegaard Rolskov, L, Zuwala, K, Gajda, P, Borup Løvschall, K, Dagnæs-Hansen, F, Banda, D H, Pietschmann, T, Tolstrup, M & Zelikin, A N 2017, ' Synthetic Polymer with a Structure-Driven Hepatic Deposition and Curative Pharmacological Activity in Hepatic Cells ', ACS Macro Letters, vol. 6, no. 935-940, pp. 935-940 . https://doi.org/10.1021/acsmacrolett.7b00471
Synthetic polymers make strong contributions as tools for delivery of biological drugs and chemotherapeutics. The most praised characteristic of polymers in these applications is complete lack of pharmacological function such as to minimize the side
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82c8191c1d250e7728b18664848f1c84
https://pure.au.dk/portal/da/publications/synthetic-polymer-with-a-structuredriven-hepatic-deposition-and-curative-pharmacological-activity-in-hepatic-cells(9134d4f3-5802-4c4e-b8ad-e593958be9de).html
https://pure.au.dk/portal/da/publications/synthetic-polymer-with-a-structuredriven-hepatic-deposition-and-curative-pharmacological-activity-in-hepatic-cells(9134d4f3-5802-4c4e-b8ad-e593958be9de).html